Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Association Between Visit Adherence and Visual Acuity in Neovascular Age-Related Macular Degeneration

Association Between Visit Adherence and Visual Acuity in Neovascular Age-Related Macular... Research Original Investigation Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration 24. Glasser D. Rewarding cost efficiency in Registry. Ophthalmology. 2018;125(4):522-528. 27. Busbee BG, Ho AC, Brown DM, et al; HARBOR Medicare’s merit-based incentive payment system. doi:10.1016/j.ophtha.2017.10.010 Study Group. Twelve-month efficacy and safety of Ophthalmology. 2019;126(2):189-191. doi:10.1016/j. 0.5 mg or 2.0 mg ranibizumab in patients with 26. Martin DF, Maguire MG, Ying GS, Grunwald JE, ophtha.2018.09.025 subfoveal neovascular age-related macular Fine SL, Jaffe GJ; CATT Research Group. degeneration. Ophthalmology. 2013;120(5):1046- 25. Rao P, Lum F, Wood K, et al. Real-world vision in Ranibizumab and bevacizumab for neovascular 1056. doi:10.1016/j.ophtha.2012.10.014 age-related macular degeneration patients treated age-related macular degeneration. N Engl J Med. with single anti-vegf drug type for 1 year in the IRIS 2011;364(20):1897-1908. doi:10.1056/ NEJMoa1102673 Invited Commentary Association Between Visit Adherence and Visual Acuity in Neovascular Age-Related Macular Degeneration Shriji Patel, MD; Paul Sternberg Jr, MD The secondary analysis of Comparison of Age-Related Macu- 1091 patients (92.6%) had 100% visit constancy during the lar Degeneration Treatment Trial (CATT) data performed by study period, with at least 1 visit in each 3-month interval. How- Ramakrishnan et al in this issue of JAMA Ophthalmology ever, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Association Between Visit Adherence and Visual Acuity in Neovascular Age-Related Macular Degeneration

Patel, Shriji; Sternberg, Paul
JAMA Ophthalmology , Volume 138 (3) – Mar 6, 2020
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/association-between-visit-adherence-and-visual-acuity-in-neovascular-sCEraB0JX3

References (5)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2019.4644
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration 24. Glasser D. Rewarding cost efficiency in Registry. Ophthalmology. 2018;125(4):522-528. 27. Busbee BG, Ho AC, Brown DM, et al; HARBOR Medicare’s merit-based incentive payment system. doi:10.1016/j.ophtha.2017.10.010 Study Group. Twelve-month efficacy and safety of Ophthalmology. 2019;126(2):189-191. doi:10.1016/j. 0.5 mg or 2.0 mg ranibizumab in patients with 26. Martin DF, Maguire MG, Ying GS, Grunwald JE, ophtha.2018.09.025 subfoveal neovascular age-related macular Fine SL, Jaffe GJ; CATT Research Group. degeneration. Ophthalmology. 2013;120(5):1046- 25. Rao P, Lum F, Wood K, et al. Real-world vision in Ranibizumab and bevacizumab for neovascular 1056. doi:10.1016/j.ophtha.2012.10.014 age-related macular degeneration patients treated age-related macular degeneration. N Engl J Med. with single anti-vegf drug type for 1 year in the IRIS 2011;364(20):1897-1908. doi:10.1056/ NEJMoa1102673 Invited Commentary Association Between Visit Adherence and Visual Acuity in Neovascular Age-Related Macular Degeneration Shriji Patel, MD; Paul Sternberg Jr, MD The secondary analysis of Comparison of Age-Related Macu- 1091 patients (92.6%) had 100% visit constancy during the lar Degeneration Treatment Trial (CATT) data performed by study period, with at least 1 visit in each 3-month interval. How- Ramakrishnan et al in this issue of JAMA Ophthalmology ever,

Journal

JAMA Ophthalmology – American Medical Association

Published: Mar 6, 2020

There are no references for this article.